… HA per 0.5-mL dose from the following influenza strains: A/New … The control product was
licensed trivalent influenza vaccine (… μg of HA per 0.5-mL dose from the same 3 influenza strains …

… We conducted a phase IIIb–IV, multicenter, randomized, double-blind, active-controlled
trial … hemagglutinin per strain) with standard-dose trivalent, inactivated influenza vaccine (IIV3-SD …

… , controlled, multicenter, phase II study to evaluate the immunogenicity and safety of an
investigational intradermal (ID) trivalent influenza vaccine (TIV) and a high-dose (… with ID vaccine …

… phase IIIb, multicenter, randomized, double-blind, controlled trial was conducted to compare
High-Dose (HD) trivalent inactivated influenza vaccine … ) to standard dose (SD) vaccine (15 …

… to establish lot-to-lot consistency of influenza vaccines. In this analysis, the double-dose IIV4
did not reach superiority to the standard-dose in the overall population, the older age group …

… influenza vaccination, and vaccination coverage in this age-range remains low.A series of
population-based studies of influenza vaccination … in recent years, vaccine uptake remains …

… at high risk for influenza, the immunogenicity … influenza vaccine with the novel intradermal
(ID) injection system. In the previous exploratory phase I/II study of the ID vaccine with a dose …

… efficacy of influenza vaccines. In 2015, we did a phase 1 trial of an oral influenza vaccine,
VXA… the vaccine to the current phase 2 trial. The aim of this study was to evaluate efficacy of the …

… Despite their global use these vaccines must … for Influenza vaccines addressing these issues
and here we report the results of a Phase Ib trial of a novel synthetic Influenza vaccine (FLU-…

… Our results suggest that influenza vaccine delivered by HD-MAP was safe and well tolerated,
with evidence to suggest that dose-sparing and enhanced immune responses are induced …